NCT02593071View on ClinicalTrials.gov

Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.

PHASE2CompletedINTERVENTIONAL
Enrollment

1,330

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Respiratory Syncytial Virus (RSV)
Interventions
BIOLOGICAL

RSV-F Vaccine

BIOLOGICAL

Phosphate Buffer Placebo

Trial Locations (10)

30281

Clinical Research Atlanta, Stockbridge

37203

Clinical Research Associates, Nashville

44122

Rapid Medical Research, Cleveland

54401

Marshfield Clinical Research Foundation, Wausau

66219

Johnson County Clin-Trials, Lenexa

75234

Research Across America, Dallas

78229

Clinical Trials of Texas, San Antonio

84088

Advanced Clinical Research, West Jordan

96001

Nothern California Clinical Research, Redding

98101

Group Health Research Institute, Seattle

Sponsors

Lead Sponsor

Novavax
All Listed Sponsors
lead

Novavax

INDUSTRY

NCT02593071 - Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year. | Biotech Hunter | Biotech Hunter